Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements

Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements

Abstract Background We aimed to examine whether patients with de novo and relapsed/progressed stage IIIB–IV non-small cell lung cancer (NSCLC) without epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) mutations have different prognoses. Methods This retrospective study anal...

Full description

Bibliographic Details
Main Authors: Byeong-Chan Oh, Ae-Ryeo Cho, Jin Hyun Nam, So-Young Yang, Min Ji Kim, Sun-Hong Kwon, Eui-Kyung Lee
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Cancer
Subjects:
Non-small cell lung cancer
Overall survival
Treatment pattern
De novo
Recurrence
Real-world data
Online Access:https://doi.org/10.1186/s12885-023-10950-y

Internet

https://doi.org/10.1186/s12885-023-10950-y

Similar Items